Novartis AG Adjustments For Increase Decrease In Other Current Liabilities
Novartis AG (NVSEF) reported Adjustments For Increase Decrease In Other Current Liabilities of $247.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-02-04
- Novartis AG adjustments for increase decrease in other current liabilities for the quarter ending 2025-06-30 was $624.00M, a 37.85% decline year-over-year.
- Novartis AG adjustments for increase decrease in other current liabilities for the quarter ending 2024-06-30 was $1.00B, a 65.95% increase year-over-year.
- Novartis AG adjustments for increase decrease in other current liabilities for the quarter ending 2023-06-30 was $605.00M, a 28.18% increase year-over-year.
- Novartis AG adjustments for increase decrease in other current liabilities for the quarter ending 2022-06-30 was $472.00M.
| Period end | Adjustments For Increase Decrease In Other Current Liabilities 3 month | Adjustments For Increase Decrease In Other Current Liabilities 3 month as first filed | Adjustments For Increase Decrease In Other Current Liabilities 6 month | Adjustments For Increase Decrease In Other Current Liabilities 6 month as first filed | Adjustments For Increase Decrease In Other Current Liabilities 12 month | Adjustments For Increase Decrease In Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $247.00M 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $624.00M 6-K · filed 2025-07-17 | $440.00M 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $1.06B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $1.00B 6-K · filed 2025-07-17 | $744.00M 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $1.33B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $605.00M 6-K · filed 2024-07-18 | $623.00M 6-K · filed 2023-07-18 | $531.00M 6-K · filed 2024-07-18 | $679.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $426.00M 20-F · filed 2025-01-31 | $658.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $472.00M 6-K · filed 2023-07-18 | -$112.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $671.00M 20-F · filed 2024-01-31 | $772.00M 20-F · filed 2022-02-02 | ||||
| 2020-12-31 | $211.00M 20-F/A · filed 2023-05-15 | |||||
| 2019-12-31 | $1.17B 20-F · filed 2022-02-02 | |||||
| 2018-12-31 | $941.00M 20-F · filed 2021-01-26 | $891.00M 20-F · filed 2019-01-30 | ||||
| 2017-12-31 | $1.41B 20-F · filed 2020-01-29 | $816.00M 20-F · filed 2019-01-30 | ||||
| 2016-12-31 | $505.00M 20-F · filed 2019-01-30 |